Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/134025
Title: The effectiveness of adjunct mindfulness-based intervention in treatment of bipolar disorder: A systematic review and meta-analysis
Author: Chu, Che Sheng
Stubbs, Brendon
Chen, Tien-Yu
Tang, Chia-Hung
Li, Dian-Jeng
Yang, Wei Cheng
Wu, Ching Kuan
Carvalho, André F.
Vieta i Pascual, Eduard, 1963-
Miklowitz, David J.
Tseng, Ping Tao
Lin, Pao Yen
Keywords: Trastorn bipolar
Teràpia cognitiva
Anàlisi de conducta
Manic-depressive illness
Cognitive therapy
Behavioral assessment
Issue Date: 1-Jan-2018
Publisher: Elsevier B.V.
Abstract: BACKGROUND: Mindfulness-based interventions (MBIs) have been increasingly used as an adjunctive treatment to pharmacotherapy for a few psychiatric disorders. However, few studies have investigated the efficacy of MBIs in bipolar disorder (BD). METHODS: We performed a systematic review and meta-analysis to evaluate the efficacy of MBIs as an adjunctive treatment in BD. Major electronic databases were independently searched by two authors for controlled and uncontrolled studies which examined the effects of MBIs on psychiatric symptoms in subjects with BD. Data from original studies were synthesized by using a random effects model. RESULTS: Twelve trials were eligible for inclusion into current meta-analysis, including three controlled studies (n=132) and nine uncontrolled studies (n=142). In within-group analysis, MBIs significantly reduced depressive (7 studies, n=100, Hedges' g=0.58, p<0.001) and anxiety (4 studies, n=68, Hedges' g=0.34, p=0.043) symptoms, but not manic symptoms (6 studies, n=89, Hedges' g=0.09, p=0.488) and cognition (3 studies, n=43, Hedges' g=0.35, p=0.171), compared to baseline. In between-group analysis (intervention group versus waiting list group, all patients with BD), MBIs did not reduce depressive (3 studies, n=132, Hedges' g=0.46, p=0.315) or anxiety (3 studies, n=132, Hedges' g=0.33, p=0.578) symptoms. LIMITATIONS: Only three controlled trials compared MBIs to control conditions. CONCLUSIONS: Our meta-analysis showed significantly beneficial effects on depressive and anxiety symptoms of BD patients in within-group analysis. However, this significance was not observed in comparison with the control groups. Further clinical trials are warranted to investigate the differences in the benefits of MBIs between treatment and control subjects.
Note: Versió postprint del document publicat a: https://doi.org/10.1016/j.jad.2017.08.025
It is part of: Journal of Affective Disorders, 2018, vol. 225, p. 234-245
URI: http://hdl.handle.net/2445/134025
Related resource: https://doi.org/10.1016/j.jad.2017.08.025
ISSN: 0165-0327
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
673281.pdf765.1 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons